AB Science S.A. | Ownership
Companies that own AB Science S.A.
TIAA-CREF Investment Management LLC
51,671
0.13%
0
0%
03/31/2018
Banque Degroof Petercam Luxembourg SA
40,000
0.1%
0
0.07%
09/30/2017
DWS Investment GmbH
21,000
0.05%
-9,000
0%
07/31/2018
Lyxor International Asset Management SAS
20,854
0.05%
0
0%
09/05/2018
Bovay & Partenaires S.A.
20,000
0.05%
0
0.16%
06/30/2017
SSgA Funds Management, Inc.
14,064
0.03%
0
0%
09/06/2018
Tredje AP-fonden
13,669
0.03%
0
0%
06/30/2017
UBS AG (Investment Management)
8,508
0.02%
0
0%
01/31/2018
Financière de l'Arc SAS
4,000
0.01%
1,000
0.03%
12/30/2016
Allianz Global Investors GmbH (France)
2,044
0.01%
-622
0%
12/31/2015
Address |
3, Avenue George V Paris Ile-de-France 75008 France
|
Employees
|
- |
Website |
http://www.ab-science.com |
Updated |
07/08/2019 |
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. |